Original articles

Pulmonary colloid adenocarcinoma: Clinical pathological analysis of 4 cases and review of literature

Expand
  • 1. Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    2. Department of Radiology, Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Shanghai 201801, China

Received date: 2019-08-01

  Online published: 2019-12-25

Abstract

Objective: To investigate the clinicopathological features, immunophenotype, molecular characteristics and differential diagnosis of colloid adenocarcinoma. Methods: The clinical and pathological data of 4 cases of pulmonary adenocarcinoma were retrospectively analyzed, and associated literature was reviewed. Results: All 4 patients were elderly men, aged 61-67 years, with a median age of 64 years. Three of them had a history of smoking. The clinical manifestations were non-specific symptoms such as fatigue and cough, or without symptoms. The tumors were located in right upper lobe in 3 cases and right lower lobe in 1 case; 3 cases were peripheral located and 1 case almost occupied the entire lobe. The maximum diameter was 1.6-12.0 cm. The cut surface was grayish white, jelly-like and shiny. Microscopically, the tumor showed abundant mucin pools which destroyed the walls of alveolar spaces. The tumor cells showed goblet or signet-ring morphology, with moderate nuclear atypia and low mitotic rate, presenting singly, in small clusters or micropapillary clusters. Tumor cells floated in the mucin pool and a small number of tumor cells might line the alveolar space. Psammoma bodies could be seen in 2 cases. Immunophenotyping showed that 4 cases expressed CK7 and MUC-1, 1 case expressed CK20, 3 cases expressed TTF-1 and NapsinA(1 diffuse and 2 focal), 2 cases expressed CDX-2, MUC-2 and Villin, 3 cases expressed MUC5AC. Molecular detection showed KRAS mutation in one case. Conclusions: Pulmonary adenocarcinoma is rarely seen. The pathological diagnosis depends on histopathological examination and immunohistochemical staining. The differential diagnosis includes primary mucinous tumor of lung and metastatic mucinous adenocarcinoma. Most cases of pulmonary adenocarcinoma have a good prognosis, but the presence of non-colloid component, interstitial infiltration and micropapillary structure suggests a worse prognosis.

Cite this article

XU Haimin, CHEN Xiaoyan, ZHANG Jing, WANG Chaofu . Pulmonary colloid adenocarcinoma: Clinical pathological analysis of 4 cases and review of literature[J]. Journal of Diagnostics Concepts & Practice, 2019 , 18(06) : 649 -654 . DOI: 10.16150/j.1671-2870.2019.06.009

References

[1] Travis WD, Brambilla E, Burke AP, et al. WHO Classification oftumours of the lung, pleura, thymus and heart[M]. Lyon: IARC Press, 2015:40-41.
[2] Zenali MJ, Weissferdt A, Solis LM, et al. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung[J]. Hum Pathol, 2015, 46(6): 836-842.
[3] Sonzogni A, Bianchi F, Fabbri A, et al. Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma[J]. J Pathol Clin Res, 2017, 3(2):139-152.
[4] Cha YJ, Shim HS, Han J, et al. Clinicopathologic ana-lysis of 10 cases of pulmonary colloid adenocarcinoma and prognostic implication of invasive micropapillary component[J]. Pathol Res Pract, 2018, 214(12):2093-2098.
[5] Masai K, Sakurai H, Suzuki S, et al. Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases[J]. JSurg Oncol, 2016, 114(2):211-215.
[6] Rossi G, Murer B, Cavazza A, et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special refe-rence to CDX-2 homeobox gene and MUC2 expression[J]. Am J Surg Pathol, 2004, 28(4):442-452.
[7] Graeme-Cook F, Mark EJ. Pulmonary mucinous cystic tumors of borderline malignancy[J]. Hum Pathol, 1991, 22(2):185-190.
[8] Moran CA, Hochholzer L, Fishback N, et al. Mucinous (so-called colloid) carcinomas of lung[J]. Mod Pathol, 1992, 5(6): 634-638.
[9] Gao ZH, Urbanski S J. The spectrum of pulmonary mu-cinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of litera-ture[J]. Am J Clin Pathol, 2005, 124(1):62-70.
[10] Berger K L, Nicholson S A, Dehdashti F, et al. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features[J]. Am J Roentgenol, 2000, 174(4):1005-1008.
[11] Shim S S, Han J. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation[J]. Ann Nucl Med, 2010, 24(5):357-362.
[12] Miyake A, Okudela K, Matsumura M, et al. Update on the potential significance of psammoma bodies in lung adenocarcinoma from a modern perspective[J]. Histopatho-logy, 2018, 72(4):609-618.
[13] Chang JC, Montecalvo J, Borsu L, et al. Bronchiolar adenoma: expansion of the concept of ciliated mucono-dular papillary tumors with proposal for revised terminology based on morphologic, immunophenotypic, and genomic analysis of 25 cases[J]. Am J Surg Pathol, 2018, 42(8):1010-1026.
[14] Chuang H W, Liao J B, Chang H C, et al. Ciliated muconodular papillary tumor of the lung: a newly defined peripheral pulmonary tumor with conspicuous mucin pool mimicking colloid adenocarcinoma: a case report and review of literature[J]. Pathol Int, 2014, 64(7):352-357.
[15] 陈晓炎, 杨晓群, 袁菲, 等. 肺纤毛黏液结节性乳头状肿瘤2例临床病理分析及文献复习[J]. 诊断学理论与实践, 2018, 17(5):575-580.
[16] Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung[J]. Appl Immunohistochem Mol Morphol, 2011, 19(4):313-317.
[17] Rossi G, Cavazza A, Righi L, et al. Napsin-A, TTF-1, EGFR, and ALK status determination in lung primary and metastatic mucin-producing adenocarcinomas[J]. Int J Surg Pathol, 2014, 22(5):401-407.
[18] Kalhor N. Colloid carcinoma of the lung: Current views[J]. Semin Diagn Pathol, 2014, 31(4):265-270.
[19] Morita K, Nagashima A, Takemoto N, et al. Primary pulmonary mucinous (colloid) adenocarcinoma with postope-rative bone metastasis[J]. Ann Thorac Cardiovas Surg, 2014, 20(Suppl):677-681.
Outlines

/